Clinical Trial Update: Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of high-dose oral clarithromycin as salvage therapy in relapsed or refractory extranodal marginal zone lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

Sponsor: Andres J. M. Ferreri | Conditions: Lymphoma | Phase 2 | Status: COMPLETED